COMMUNIQUÉS West-GlobeNewswire

Announcement no. 2/2019 - Share Buyback Programme
22/02/2019
Announcement no. 2/2019 22 February 2019 Coloplast initiates the second part of the DKK 1bn share buy-back programme Coloplast A/S is initiating the second part of the share buy-back programme totalling up to DKK 1bn, [...]
BioPorto Announces Annual Report 2018
22/02/2019
February 22, 2019 Announcement no. 2 Annual Report 2018 Full speed ahead Highlights from the Annual Report 2018 Revenue growth of 80% from sales of The NGAL Test™ in U.S. and 18% in rest of the world in 2018 Total [...]
Novo Nordisk: Notice for the Annual General Meeting of Novo Nordisk A/S
22/02/2019
Bagsværd, Denmark, 22 February 2019 - The Annual General Meeting of Novo Nordisk A/S will be held on: - Thursday 21 March 2019 at 2.00 pm (CET) at Bella Center, Center Boulevard 5, DK-2300 Copenhagen S, Denmark. The [...]
Xbrane Biopharma releases Year-end report for 2018
22/02/2019
Press release 2019-02-22 Xbrane Biopharma AB's (publ.) (" Xbrane ") Year-end report for 2018 is now available on the Company's website, www.xbrane.com . The fourth quarter 2018 in summary Revenue amounted to SEK 4,896 [...]
Notice of Nexstim Plc 2018 Full Year Results
22/02/2019
Company announcement, Helsinki, 22.02.2019 at 9am (EET) Notice of Nexstim Plc 2018 Full Year Results Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), the targeted neuromodulation company developing and [...]
Spineway :
22/02/2019
The shareholders of Spineway are invited to attend the Ordinary and Extraordinary General Shareholders’ Meeting to be held on Friday, 8 March 2019, at noon , at the company’s registered office. Notice of the meeting [...]
SPINEWAY : Modalités de mise à disposition des documents prépartoires à l’Assemblée Générale du 8 mars 2019
22/02/2019
Les actionnaires de Spineway sont invités à participer à l’Assemblée Générale Mixte qui se déroulera au siège social de la société le vendredi 8 mars 2019 à 12 heures. L’avis de réunion comportant l’ordre du jour et les [...]
NeuroSearch – Updated financial calendar for 2019
22/02/2019
Announcement 22 February 2019 NeuroSearch A/S (NEUR) hereby announces an updated company’s financial calendar for 2019. 25 February 2019 Annual Report 2018 29 April 2019 Annual General Meeting 30 August 2019 Interim [...]
ESPERITE NV (ESP) AND PBKM (FAMICORD GROUP) SIGN EXCLUSIVE AGREEMENT REGARDING POTENTIAL ACQUISITION OF CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS.
22/02/2019
Amsterdam, the Netherlands – 22 February 2019 Esperite N.V. (Euronext: ESP) and Polski Bank Komórek Macierzystych S.A. (WSE: PBKM) are pleased to announce that they have entered into an Memorandum of Understanding (MoU [...]
ObsEva SA to Participate in Upcoming Investor Conferences
22/02/2019
Geneva, Switzerland and Boston, MA – February 22, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]
Clarification Regarding Press Release Issued by Unrelated Third Party
22/02/2019
TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ” or the “ Company ”), is providing an update regarding a press release (the “ Press Release ”) issued [...]
Early Warning News Release
22/02/2019
VANCOUVER, British Columbia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Drew Malcolm (“ Malcolm ”), a shareholder of Ascent Industries Corp. (the “ Issuer ”) makes the following announcement in accordance with National [...]
Cronos Group Inc. Shareholders Approve C$2.4 Billion Strategic Investment from Altria Group, Inc.
21/02/2019
TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announced that at a Special Meeting held today, the Company’s shareholders overwhelmingly [...]
Alder BioPharmaceuticals® to Present at the 8th Annual SVB Leerink Global Healthcare Conference
21/02/2019
BOTHELL, Wash., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
bioLytical Laboratories Earns MDSAP Certification, Highest Quality Standard in Medical Device Industry
21/02/2019
Audits confirm bioLytical’s Quality Management System fulfils latest standards for multiple regulatory jurisdictions including US FDA and Health Canada. RICHMOND, British Columbia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- [...]
Moleculin Biotech, Inc. Reports Financial Results for the Year Ended December 31, 2018
21/02/2019
HOUSTON, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical-stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
Profound Medical to Release Fourth Quarter and Full Year 2018 Financial Results on March 7 – Conference Call to Follow
21/02/2019
TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that combines real-time Magnetic Resonance (“MR [...]
Flexion Therapeutics Announces New In Vitro Data Showing Protective Effects of Triamcinolone Acetonide on Cartilage
21/02/2019
Study conducted in collaboration with MIT showed that triamcinolone acetonide had protective effects on inflamed and/or injured cartilage in an established preclinical model Data presented in “late breaker” session at [...]
Globus Medical Reports Full Year and Fourth Quarter 2018 Results
21/02/2019
AUDUBON, Pa., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, [...]

Pages